Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: Comparing patients with and without solid organ transplantation

Author:

Lee Stephen B.1ORCID,Dai Ran2,French Evan3,Anzalone Jerrod A.2,Olex Amy L.3,Ge Jin4,Schissel Makayla2,Agarwal Gaurav5,Vinson Amanda6,Madhira Vithal7,Mannon Roslyn B.8,

Affiliation:

1. Department of Medicine, Division of Infectious Diseases University of Saskatchewan Regina Canada

2. Department of Biostatistics University of Nebraska Medical Center Omaha Nebraska USA

3. Virginia Commonwealth University Wright Center for Clinical and Translational Research Richmond Virginia USA

4. Department of Medicine Division of Gastroenterology and Hepatology University of California San Francisco California USA

5. Department of Internal Medicine Division of Nephrology University of Alabama at Birmingham Birmingham Alabama USA

6. Department of Medicine Division of Nephrology Dalhousie University Halifax Canada

7. Palila Software Reno Nevada USA

8. Department of Internal Medicine Division of Nephrology University of Nebraska Medical Center Omaha Nebraska USA

Abstract

AbstractBackgroundWhile coronavirus disease 2019 (COVID‐19) is no longer a public health emergency, certain patients remain at risk of severe outcomes. To better understand changing risk profiles, we studied the risk factors for patients with and without solid organ transplantation (SOT) through the various waves of the pandemic.MethodsUsing the National COVID Cohort Collaborative we studied a cohort of adult patients testing positive for COVID‐19 between January 1, 2020, and May 2, 2022. We separated the data into waves of COVID‐19 as defined by the Centers for Disease Control. In our primary outcome, we used multivariable survival analysis to look at various risk factors for hospitalization in those with and without SOT.ResultsA total of 3,570,032 patients were captured. We found an overall risk attenuation of adverse COVID‐19‐associated outcomes over time. In both non‐SOT and SOT populations, diabetes, chronic kidney disease, and congestive heart failure were risk factors for hospitalization. For SOT specifically, longer time periods between transplant and COVID‐19 were protective and age was a risk factor. Notably, asthma was not a risk factor for major adverse renal cardiovascular events, hospitalization, or mortality in either group.ConclusionsOur study provides a longitudinal view of the risks associated with adverse COVID‐related outcomes amongst SOT and non‐SOT patients, and how these risk factors evolved over time. Our work will help inform providers and policymakers to better target high‐risk patients. image

Funder

National Center for Advancing Translational Sciences

Liver Center, University of California, San Francisco

National Institute of General Medical Sciences

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3